US Patent Issued to Belite Bio, The Trustees Of Columbia University In The City Of New York on Aug. 25 for "Methods of treating RBP4 related diseases with triazolopyridines" (California, New York Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,700, issued on Aug. 25, was assigned to Belite Bio Inc (Grand Cayman, Cayman Islands) and The Trustees Of Columbia University In The City Of New York.

"Methods of treating RBP4 related diseases with triazolopyridines" was invented by Yu-Hsin Tom Lin (San Diego), Cheng-Chi Irene Wang (San Diego) and Konstantin Petrukhin (New Windsor, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as obesity and the like."

The patent was filed on March 25, 2024, ...